Watch Ticker

Armata Pharmaceuticals, Inc. Common Stock

Go to Armata Pharmaceuticals, Inc. Common Stock Website

$2.58

0.01 (0.39%)

Live

Previous Close

$2.57

Day Range

$2.58 - $2.6999

Previous Day Range

$2.55 - $2.7

Market Cap

$98.1 million USD

Day Vol.

12189

Previous Day Vol.

6121

Currency

USD

Primary Exchange

NYSE American, LLC

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is devel...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - 8MM Bronchiectasis Market Opportunity Assessment and Forecasts, 2033 - Pipeline Innovations Expected to Add $1.8 Billion in Bronchiectasis Market Sales

The report forecasts the bronchiectasis treatment market to reach $3.7 billion by 2033, driven by emerging pipeline agents expected to contribute an additional $1.8 billion in sales.

Related tickers: INSM, SNY, REGN, ARMP, CSLLY, AZN.

Read Full Article

Delveinsight - Phage Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight

The phage therapy market is experiencing significant growth due to the increasing prevalence of antibiotic-resistant infections and the growing interest in alternative treatments. Advances in biotechnology and ongoing research are driving innovation in phage-based therapeutics, offering a promising solution to combat multidrug-resistant pathogens.

Related tickers: ARMP, PHGE.

Read Full Article

Trending Tickers

Please sign in to view